Immunological markers of successful implantation in assisted reproductive technologies

1. WHO. 1 in 6 people globally affected by infertility: WHO. 4 April 2023. Available at: https://www.who.int/news/item/04-04-2023-1-in-6-people-globally-affected-by-infertility
2. Alecsandru D., García-Velasco J.A. Why natural killer cells are not enough: a further understanding of killer immunoglobulin-like receptor and human leukocyte antigen. Fertil. Steril. 2017; 107(6): 1273-8. https://dx.doi.org/10.1016/j.fertnstert.2017.04.018
3. Saito S. Role of immune cells in the establishment of implantation and maintenance of pregnancy and immunomodulatory therapies for patients with repeated implantation failure and recurrent pregnancy loss. Reprod. Med. Biol. 2024; 23(1): e12600. https://dx.doi.org/10.1002/rmb2.12600
4. Chaaithanya I.K., Rajalingam R. Emerging roles of natural killer cell ligands-HLA-E, HLA-F, HLA-G, MICA, and MICB-in in vitro fertilization outcomes. Front. Genet. 2025; 16: 1661511. https://dx.doi.org/10.3389/fgene.2025.1661511
5. Shima T., Nakashima A., Yasuda I., Ushijima A., Inada K., Tsuda S. et al. Uterine CD11c+ cells induce the development of paternal antigen-specific Tregs via seminal plasma priming. J. Reprod. Immunol. 2020; 141: 103165. https://dx.doi.org/10.1016/j.jri.2020.103165
6. Von Woon E., Greer O., Shah N., Nikolaou D., Johnson M., Male V. Number and function of uterine natural killer cells in recurrent miscarriage and implantation failure: a systematic review and meta-analysis. Hum. Reprod. Update. 2022; 28(4): 548-82. https://dx.doi.org/10.1093/humupd/dmac006
7. Amjadi F., Zandieh Z., Mehdizadeh M., Aghajanpour S., Raoufi E., Aghamajidi A. et al. The uterine immunological changes may be responsible for repeated implantation failure. J. Reprod. Immunol. 2020; 138: 103080. https://dx.doi.org/10.1016/j.jri.2020.103080
8. Genest G., Hochberg A., Boivin M., Ferreira A., Liu Z., Beauchamp C. et al. Outcomes of ultimpro testing implementation for patients with unexplained recurrent implantation failure: a single-center retrospective cohort study. Am. J. Reprod. Immunol. 2025; 94(2): e70131. https://dx.doi.org/10.1111/aji.70131
9. Lédée N., Petitbarat M., Dray G., Chevrier L., Kazhalawi A., Rahmati M. et al. Endometrial immune profiling and precision therapy increase live birth rate after embryo transfer: a randomised controlled trial. Front. Immunol. 2025; 16: 1523871. https://dx.doi.org/10.3389/fimmu.2025.1523871
10. Beer A.E., Billingham R.E. Immunobiology of mammalian reproduction. Adv. Immunol. 1971; 14: 1-84. https://dx.doi.org/10.1016/s0065-2776(08)60283-7
11. Фонталин Л.Н. Иммунологическая толерантность. М.: Медицина; 1978. 311 c. [Fontalin L.N. Immunological Tolerance. Moscow: Medicine; 1978. 311 p. (in Russian)].
12. Markova K.L., Kozyreva A.R., Sokolov D.I., Selkov S.A. Microvesicles produced by natural killer cells regulate the formation of blood vessels. Bull. Exp. Biol. Med. 2020; 170(1): 123-7. https://dx.doi.org/10.1007/s10517-020-05017-y
13. He Z., Liu D., Mu Y., Li H. Decoding the maternal–fetal dialogue: NK cell education in reproductive outcomes. Biol. Reprod. 2025; 113(4): 717-29. https://dx.doi.org/10.1093/biolre/ioaf124
14. Whettlock E.M., Woon E.V., Cuff A.O., Browne B., Johnson M.R., Male V. Dynamic changes in uterine NK cell subset frequency and function over the menstrual cycle and pregnancy. Front. Immunol. 2022; 13: 880438. https://dx.doi.org/10.3389/fimmu.2022.880438
15. Кречетов С.П., Хорошкеева О.В., Тетруашвили Н.К., Кречетова Л.В., Янкевич Т.Э., Трофимов Д.Ю., Сухих Г.Т. Связь исходов беременности при иммуноцитотерапии привычного выкидыша с генотипами иммуноглобулиноподобных рецепторов клеток-киллеров и их лигандов у матери и плода. Иммунология. 2024; 45(6): 742-54. https://dx.doi.org/10.33029/1816-2134-2024-45-6-742-754 [Krechetov S.P., Khoroshkeeva O.V., Tetruashvili N.K., Krechetova L.V., Yankevic T.Е., Trofimov D.Yu., Sukhikh G.T. Association of pregnancy outcomes after immunocytotherapy of recurrent pregnancy loss with genotypes of killer cell immunoglobulin-like receptors and their ligands in mother and fetus. Immunologiya. 2024; 45(6): 742–54 (in Russian). https://dx.doi.org/10.33029/1816-2134-2024-45-6-742-754].
16. Jiang L., Fei H., Jin X., Liu X., Yang C., Li C. et al. Extracellular vesicle-mediated secretion of HLA-E by trophoblasts maintains pregnancy by regulating the metabolism of decidual NK cells. Int. J. Biol. Sci. 2021; 17(15):4377-95. https://dx.doi.org/10.7150/ijbs.63390
17. Krechetov S.P., Khoroshkeeva O.V., Jankevic T.E., Shirokov Y.V., Borovikov P.I., Krechetova L.V. et al. Natural killers in pregnancy: servants of two masters. bioRxiv 2025.11.11.685990. https://dx.doi.org/10.1101/2025.11.11.685990
18. Jiang C., Geng M., Zhang C., She H., Wang D., Wang J. et al. The synergy of morphokinetic parameters and sHLA-G in cleavage embryo enhancing implantation rates. Front. Cell Dev. Biol. 2024; 12: 1417375. https://dx.doi.org/10.3389/fcell.2024.1417375
19. Bazhenov D., Mikhailova V., Nikolaenkov I., Markova K., Salloum Z., Kogan I. et al. The uteroplacental contact zone cytokine influence on NK cell cytotoxicity to trophoblasts. Gynecological Endocrinology. 2020; 36(S1): 1-6. https://dx.doi.org/10.1080/09513590.2020.1816715
20. Benkhalifa M., Zidi W., Bahri H., Mahjoub S., Boundhraa K., Sanhaji H. et al. Circulating MMP-7 and VEGF as potential predictive biomarkers for recurrent implantation failures. Zygote. 2021; 29(5): 365-71. https://dx.doi.org/10.1017/S0967199421000113
21. Braun A.S., Vomstein K., Reiser E., Tollinger S., Kyvelidou C., Feil K. et al. NK and T cell subtypes in the endometrium of patients with recurrent pregnancy loss and recurrent implantation failure: implications for pregnancy success. J. Clin. Med. 2023; 12(17): 5585. https://dx.doi.org/10.3390/jcm12175585
22. Tohma Y.A., Musabak U., Gunakan E., Akilli H., Onalan G., Zeyneloglu H.B. The role of analysis of NK cell subsets in peripheral blood and uterine lavage samples in evaluation of patients with recurrent implantation failure. J. Gynecol. Obstet. Hum. Reprod. 2020; 101793. https://dx.doi.org/10.1016/j.jogoh.2020.101793
23. Donoghue J.F., Paiva P., Teh W.T., Cann L.M., Nowell C., Rees H. et al. Endometrial uNK cell counts do not predict successful implantation in an IVF population. Hum. Reprod. 2019; 34(12): 2456-66. https://dx.doi.org/10.1093/humrep/dez194
24. Alecsandru D., Barrio A., Garrido N., Aparicio P., Pellicer A., Moffett A. et al. Parental human leukocyte antigen-C allotypes are predictive of live birth rate and risk of poor placentation in assisted reproductive treatment. Fertil. Steril. 2020; 114(4): 809-17. https://dx.doi.org/10.1016/j.fertnstert.2020.05.008
25. Piekarska K., Radwan P., Tarnowska A., Wiśniewski A., Radwan M., Wilczyński J.R. et al. ERAP, KIR, and HLA-C Profile in recurrent implantation failure. Front. Immunol. 2021; 12: 755624. https://dx.doi.org/10.3389/fimmu.2021.755624
26. Cozzolino M., Pellegrini L., Tartaglia S., Mancuso S., De Angelis F., Vaquero E. et al. Subcutaneous G-CSF administration improves IVF outcomes in patients with recurrent implantation failure presenting a KIR/HLA-C mismatch. J. Reprod. Immunol. 2024; 165: 104310. https://dx.doi.org/10.1016/j.jri.2024.104310
27. Abel A.M., Yang C., Thakar M.S., Malarkannan S. Natural killer cells: development, maturation, and clinical utilization. Front. Immunol. 2018; 9: 1869. https://dx.doi.org/10.3389/fimmu.2018.01869
28. Jiang R., Yan J., Xing J., Wang Z., Liu Y., Wu H. et al. Abnormal ratio of CD57+ cells to CD56+ cells in women with recurrent implantation failure. Am. J. Reprod. Immunol. 2017; 78: e12708. https://dx.doi.org/10.1111/aji.12708
29. Zhang X.X., Wu X.H. Decreased CD56+CD16-CD94+uNK cells in the mid-luteal phase in women with recurrent implantation failure are associated with IL-15 deficiency. Am. J. Reprod. Immunol. 2023; 90(6). https://dx.doi.org/10.1111/aji.13794
30. Moldenhauer L.M., Foyle K.L., Wilson J.J., Wong Y.Y., Sharkey D.J., Green E.S. et al. A disrupted FOXP3 transcriptional signature underpins systemic regulatory T cell insufficiency in early pregnancy failure. iScience. 2024; 27(2): 108994. https://dx.doi.org/10.1016/j.isci.2024.108994
31. Scarpellini F., Sbracia M. Modification of peripheric Treg and CD56brightNK levels in RIF women after egg donation, treated with GM-CSF or placebo. J. Reprod. Immunol. 2023; 158: 103983. https://dx.doi.org/10.1016/j.jri.2023.103983
32. Lu L., Lu Y., Zhang L. Regulatory T cell and T helper 17 cell imbalance in patients with unexplained infertility. Int. J. Womens Health. 2024; 16: 1033-40. https://dx.doi.org/10.2147/IJWH.S455733
33. Berdiaki A., Vergadi E., Makrygiannakis F., Vrekoussis T., Makrigiannakis A. Title: Repeated implantation failure is associated with increased Th17/Treg cell ratio, during the secretory phase of the human endometrium. J. Reprod. Immunol. 2024; 161: 104170. https://dx.doi.org/10.1016/j.jri.2023.104170
34. Cai J.Y., Tang Y.Y., Deng X.H., Li Y.J., Liang G., Meng Y.Q. et al. Recurrent implantation failure may be identified by a combination of diagnostic biomarkers: an analysis of peripheral blood lymphocyte subsets. Front. Endocrinol. (Lausanne). 2022; 13: 865807. https://dx.doi.org/10.3389/fendo.2022.865807
35. Liston A. An education in tolerance: the 2025 Nobel Prize in Physiology or Medicine. Dis. Model. Mech. 2025; 18(11): dmm052725. https://dx.doi.org/10.1242/dmm.052725
36. Yasuda I., Shima T., Moriya T., Ikebuchi R., Kusumoto Y., Ushijima A. et al. Dynamic changes in the phenotype of dendritic cells in the uterus and uterine draining lymph nodes after coitus. Front. Immunol. 2020; 11: 557720. https://dx.doi.org/10.3389/fimmu.2020.557720
37. Liu S., Wei H., Li Y., Huang C., Lian R., Xu J. et al. Downregulation of ILT4+ dendritic cells in recurrent miscarriage and recurrent implantation failure. Am. J. Reprod. Immunol. 2018; 80(4): e12998. https://dx.doi.org/10.1111/aji.12998
38. Dao Nyesiga G., Pool L., Englezou P.C., Hylander T., Ohlsson L., Appelgren D. et al. Tolerogenic dendritic cells generated in vitro using a novel protocol mimicking mucosal tolerance mechanisms represent a potential therapeutic cell platform for induction of immune tolerance. Front. Immunol. 2023; 14: 1045183. https://dx.doi.org/10.3389/fimmu.2023.1045183
39. Gori S., Soczewski E., Fernández L., Grasso E., Gallino L., Merech F. et al. Decidualization process induces maternal monocytes to tolerogenic IL-10-producing dendritic cells (DC-10). Front. Immunol. 2020; 11:1571. https://dx.doi.org/10.3389/fimmu.2020.01571
40. Blois S.M., Barrientos G., Garcia M.G., Orsal A.S., Tometten M., Cordo-Russo R.I. et al. Interaction between dendritic cells and natural killer cells during pregnancy in mice. J. Mol. Med. (Berl.). 2008; 86(7): 837-52. https://dx.doi.org/10.1007/s00109-008-0342-2
41. Sun Y., Wu S., Zhou Q., Li X. Trophoblast-derived interleukin 9 mediates immune cell conversion and contributes to maternal-fetal tolerance. J. Reprod. Immunol. 2021; 148: 103379. https://dx.doi.org/10.1016/j.jri.2021.103379
42. Chang R.Q., Li D.J., Li M.Q. The role of indoleamine-2,3-dioxygenase in normal and pathological pregnancies. Am. J. Reprod. Immunol. 2018; 79(4): e12786. https://dx.doi.org/10.1111/aji.12786
43. Wei H., Liu S., Lian R., Huang C., Chen L., Zeng Y. Abnormal expression of indoleamine 2, 3-dioxygenase in human recurrent miscarriage. Reprod. Sci. 2020; 27: 1656-64. https://dx.doi.org/10.1007/s43032-020-00196-5
44. Park M., Kim Y.S., Song H. Macrophages: a double-edged sword in female reproduction and disorders. Exp. Mol. Med. 2025; 57(2): 285-97. https://dx.doi.org/10.1038/s12276-025-01392-6
45. Chen X., Song Q.L., Li Z.H., Ji R., Wang J.Y., Ge C. et al. Deletion of ACLY disrupts histone acetylation and IL-10 secretion in trophoblasts, which inhibits M2 polarization of macrophages: a possible role in recurrent spontaneous abortion. Oxid. Med. Cell. Longev. 2022; 2022: 5216786. https://dx.doi.org/10.1155/2022/5216786
46. Zhang Y., Ma L., Hu X., Ji J., Mor G., Liao A. The role of the PD-1/PD-L1 axis in macrophage differentiation and function during pregnancy. Hum. Reprod. 2019; 34(1): 25-36. https://dx.doi.org/10.1093/humrep/dey347
47. Ding J., Yang C., Cheng Y., Wang J., Zhang S., Yan S. et al. Trophoblast-derived IL-6 serves as an important factor for normal pregnancy by activating Stat3-mediated M2 macrophages polarization. Int. Immunopharmacol. 2021; 90: 106788. https://dx.doi.org/10.1016/j.intimp.2020.106788
48. Sheng Y.R., Hu W.T., Shen H.H., Wei C.Y., Liu Y.K., Ma X.Q. et al. An imbalance of the IL-33/ST2-AXL-efferocytosis axis induces pregnancy loss through metabolic reprogramming of decidual macrophages. Cell. Mol. Life Sci. 2022; 79(3): 173. https://dx.doi.org/10.1007/s00018-022-04197-2
49. Sukka S.R., Ampomah P.B., Darville L.N.F., Ngai D., Wang X., Kuriakose G. et al. Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution. Nat. Metab. 2024; 6(9): 1736-55. https://dx.doi.org/10.1038/s42255-024-01115-7
50. Papúchová H., Saxtorph M.H., Hallager T., Jepsen I.E., Eriksen J.O., Persson G. et al. Endometrial HLA-F expression is influenced by genotypes and correlates differently with immune cell infiltration in IVF and recurrent implantation failure patients. Hum. Reprod. 2022; 37(8): 1816-34. https://dx.doi.org/10.1093/humrep/deac118
51. Namlı Kalem M., Akgun N., Kalem Z., Bakirarar B., Celik T. Chemokine(C-C motif) ligand-2 (CCL2) and oxidative stress markers in recurrent pregnancy loss and repeated implantation failure. J Assist. Reprod. Genet. 2017; 34(11): 1501-6. https://dx.doi.org/10.1007/s10815-017-0992-5

Received 06.05.2026

Accepted 02.09.2026